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Porcine urine, unlike human urine, does not contain detectable amounts of urokinase-type plasminogen activator (u-PA). The plasminogen activator 
present in porcine urine is of tissue-type (t-PA) as identified by the following criteria. (1) Porcine urine PA exhibits an M, of 65 000 similar to the 
M, of human t-PA (64-70 000) but distinct from the M, of human u-PA (55 000). (2) Antibodies against human t-PA bind and inhibit crude and 
purified porcine urine PA, while human u-PA-specific antibodies do not react with porcine urine PA. (31 i’lasminogen activation by porcine urine 
PA is markedly stimuiated in the presence of fibrinogen fragments. (4) Porcine urine PA activity is not affected by concentration of amiloride 
substantially suppressing human u-PA activity. 
Tissue-type plasminogen activator; Urokinase-type plasminogen activator: Monoclonal antibody; Porcine urine 
1. INTRODUCTION 
Two different types of plasminogen activator, uroki- 
nase-type PA (u-PA) and tissue-type PA (t-PA) catalyze 
the activation of plasminogen by cleaving the same pep- 
tide bond in the zymogen molecule. The two enzymes 
are encoded by separate genes. They differ in tissue 
distribution, M,, catalytic and immunological proper- 
ties, in their bill-?ing to fibrin and specific ell membmne 
receptors. The activators play distinct roles in fibrinoly- 
sis and in diverse processes of tissue remodelling and 
cell migration [ 1,2]. 
A PA in tissue fragments was described as early as 
1947 by Astrup and Permin [3]. Later on this activator 
was shown to be identical to vascular t-PA synthesized 
by endothelial cells. 
Urokinase-type PA was first detected in human urine 
[4] and it owes its name to this discovery. Urokinase- 
type PA was found also in urine of other mammalian 
species as mouse, rat [5] and bovine [G]. However, the 
precise origin and the possible physiological function of 
u-PA in urine are not yet well defined. Immunohisto- 
chemical investigations and in situ hybridization of 
human [7] and murine [8,9] kidney sections located u- 
PA mainly in epithelial cells of proximal and distal tu- 
bules. t-PA antigen [7] and mRNA [9] have been detec- 
ted at distinct sites of the kidney such as glomerular cells 
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and epithelial cells lining the distal part of collecting 
ducts. 
The present paper reports that porcine urine does not 
contain u-PA, but t-PA. 
2. MATERIALS AND METHODS 
2.1. Mnrerials 
Human two-chain u-PA (Ukidan) was obtained from Serono and 
human single-chain t-PA from Biopool. Glu-plasminogcn was purified 
from human plasma [IO]. CNBr-fragments of fibrinogen were prepar- 
ed according to Nieuwenhuizen [I I]. Monoclonal and polyclonal anti- 
bodies against human u-PA [ 121 and human t-PA [ 131 were generated 
and purified as described previously. 
2.2. Pwtjicalion of porcirle plasmitlogm aclir~alors 
Urine from male and female domestic pigs of different German 
breeds (Landrasse, Schwerfurter Rasse, Lcicoma Rasse) was collected 
and immediately frozen at -20°C. After thawing, all subsequent puri- 
fication steps were carried out at 4°C in the presence of 10 KIU/ml 
aprotinin. Urine was adjusted lo pH 7.5. Following ccntrifugation at 
GO00 x g for 30 min, supernatants were applied lo Zn chclate-Sepha- 
rose equilibrated with 0.02 M sodium phosphate, 0.15 M NaCI,O.Ol’% 
Twecn 80, pH 7.4 (PBS/Tw). The column was washed with cquilibra- 
tion buffer and PA was eluted with 0.05 M imidazolc and 0.3 M NaCl 
in PBSmw. Fractions with PA antigen were applied to a column of 
anti-t-PA antibody-Sepharose [I41 pre-equilibrated with PBSITw. 
After washing with I M NaCl in equilibration buffer, 1.PA-rclatcd 
antigen was cluted with 3.2 M KSCN in PBS/Tw. PA-containing 
fractions were pooled. dialyzed overnight against PBS/Tw and conccn- 
tratcd by ultrafillration ( l’eole Ij. 
Porcine heart t-PA was cxtractcd from porcine heart tissue accor- 
ding to Wallcn ct al. [IG] and subscqucntly purified by chromato- 
graphy on Zn chclatc-Scpharosc and anti-t-PA antibody-Scpharosc as 
outlined above. 
2,3. ~ssor o/p/cw~r imjicrr ocriwrror ucriai!_v 
PA activiiy was mcasurcd with a fibrin plate assay [ 171 and with a 
coupled amidolytic assay [ 181. The fibrin platc consisrcd of 1% agar- 
OX. I mg fibrin/ml, and 0.4 ,ug plasminogcn/ml. It was used to cxa- 
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mine the effects of antibodies and of amiloride on ?A activity. PA was 
preincubated for 1 11 at 37OC in the presence or absence of either 
polyclonal anti-u-PA antibody or polyclonal anti-t-PA antibody, and 
for IO min at room temperature in the presence or absence of 2-10 mM 
amiloride. In the coupled amidolytic assay various concentrations of 
PA were incubated at 37°C with OSflM plasminogen. 0.9 mM D-Val- 
Leu-Lys-p-nitroanilide, 50 mM sodium phosphate, 80 mM NaCI, 0.5 
PM BSA, 0.01% Tween 80, pI-I 7.4. PA activity was stimulated with 
0.14 mdml CNBr-fragments of fibrinogen. 
Fibrin-zymography was carried out according to Granelli-Piperno 
and Reich [l9]. 
2.4. Itnmunochemical detection of plasminogen activators 
Immunoblot ihnalysis of porcine urine PA with polyclonal and mo- 
noclonal antibodies against either human u-PA or human t-PA was 
performed as described previously [It, 131. Tissue-type PA antigen was 
estimated with a solid phase EIA using polyclonal anti-t-PA IgG for 
capturing, peroxidase-conjugated polyclonal anti-t-PA IgG for detec- 
ting bound t-PA and human t-PA as a standard [l3]. For determina- 
tion of t-PA-related antigen porcine urine was first concentrated about 
5-fold using a PM 30 membrane (Amicon) and then dialyzed against 
PIWTw. Reactivity of human t-PA-specific mAb towards porcine PA 
was dctcrmined in the same EIA using mAb (2-lO/,@ml) for capturing 
and peroxidase-conjugated polyclonal anti-t-PA IgG for quantifying 
bound PA. 
3. RESULTS 
3.1. Analysis of porcine PA by fibrin zytnography 
Gel electrophoresis of human and porcine urine fol- 
lowed by fibrin zymography reveals a significant dif- 
ference in M, of PA present in the two fluids (Fig. 1). 
In accordance with previous reports the M, of-crude and 
purified human urine PA is 55 000. By contrast, PA 
activity of porcine urine is associated with a protein of 
M, 65 000, similar to the M, of human t-PA. No lysis 
area reminiscent of u-PA is visible even after treatment 
of porcine urine with plasmin, suggesting that the inac- 
tive proenzyme form of u-PA is also not present, As 
shown below porcine urine PA reacts with antibodies 
against human t-PA and anti-t-PA antibody-Sepharose 
can be used to purify porcine urine PA (Table I). The 
M, of porcine urine PA adsorbed to and eluted from the 
affinity support compares well with the M, of crude 
porcine urine PA, purified porcine heart t-PA, and 
human t-PA (Fig. 1). 
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Fig. I. Fibrin zymography of PA activity. Crude human urine (5 ,ul. 
lane I), human u-PA (I ng, lane 2), human t-PA (0.3 ng, lane 3). 
porcine urine PA (0.3 ng. iane 4), crude porcine urine (30 ~1, lane 5) 
and porcine heart t-PA (0.3 ng. lane 6) were subjected to SDS-PAGE 
and analysed for PA activity by fibrin-overlay as described in scc- 
tion 2. 
3.2. Reactivity of antibodies agaitwl hutnan t-PA und 
human u-PA towards porcine PA 
Immunoreactivity of porcine urine PA was investigat- 
ed by immunoblot analysis and by EIA. In immunoblot 
experiments porcine urine PA and human t-PA are re- 
cognized by polyclonal and monoclona! anti-t-PA an- 
tibodies (Fig. 2). The M, of porcine urine PA estimated 
by immunoblot analysis is identical to that determined 
by fibrin zymography. Reduction of porcine urine PA 
with dithiothreitol prior to electrophoresis does not lead 
to fragmentation of the molecule suggesting that por- 
cine urine PA is present in the single chain form (not 
shown). At variance with anti-t-PA antibodies, polyclo- 
na! anti-u-PA IgG does not react with uorcine urine PA 
(Fig. 2). - 
To evaluate the extent of the observed cross-reactivity 
of anti-human t-PA antibodies with porcine PA, 21 
mAb against human t-PA [13] were analyzed for their 
capacity to bind porcine urine and heart PA. In a sand- 
wich EIA binding of t-PA-related antigen to plate-fixed 
mAb was quantified with peroxidase-conjugated poly- 
clona! anti-t-PA IgG. The assay gives identical indicator 
reactions for porcine urine PA. porcine heart t-PA and 
Table I 
Purification of t-PA-rclatcd protein from porcine urine (calculated for 1000 ml of urine) 
Urine 
Zn chclatc-Scphnrosc 
Mo~~nclo~~i\l tint body- 
Scpharo.se 
Total 
protcin* 
Wg) 
60000 
I920 
65 
I’otel 
t-PA antigen 
Wg) 
3 
2.4 
I.2 
Yield 
(%) 
IO0 
82 
41 
Purification 
factor 
I 
25 
369rl 
*Protein concciitrillions wcrc dslsrmincd :Iccording to Utlcnfricnd ct al. [IS). 
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Fig. 2. Immunoblotting of plasminogen activators. Human u-PA (40 
ng. lane 1). porcine urine PA (25 ng, lane 2) and human t-PA (25 ng. 
lane 3) wcrc subjected to SDS-PAGE under non-reducing conditions 
and blotted ontoa nitrocellulose membrane. Membranes were incubat- 
ed with monoclonal anti-t-PA antibody 31 [ 131 (A). polyclonal anti- 
t-PA antibody (B). or polyclonal anti-u-PA antibody (C) and bound 
antibodies were detected witk peroxidase-labelled anti-mouse (A) or 
anti-rabbit I@ (B.C). 
human t-PA with 17 mAb directed against 5 different 
epitopes on t-PA A- and B-chain. Four mAb. all bind- 
ing to the same epitope B on human t-PA A-chain [I 31, 
apparently have an approx. 20% lower affinity for por- 
cine t-PA as compared to human t-PA. The data docu- 
ment a high degree of immunological similarity between 
porcine and human t-PA. They provide rational ap- 
proaches for immunaffinity purification and for estima- 
tion of porcine urine PA antigen (see section 2). The 
amount of t-PA-antigen in porcine urine as calculated 
from values determined in concentrated and dialyzed 
urine samples with an EIA for human t-PA varies be- 
tween 0.5 and 5.0 ng/ml. 
3.3. hdtibiiion cm/ ~stimttkution of’ctrtalytic activity 
Polyclonal anti-t-PA antibodies strongly inhibit plas- 
minogen activation by porcine urine PA and human 
t-PA in the fibrin plate assay (Fig. 3). Under the same 
conditions. polyclonal anti-u-PA antibodies have no ef- 
fect on porcine urine PA. 
Catalytic activity of porcine urine PA is likewise not 
Table II 
Inhibition of PA activity by arniloridc 
Pcrccnt activity in the prcscncc ol 
10 mM ;Imiloridc 
Iiulllall U-PA 40% 
Crude Iiuni;w urine 50% 
I~IuI11;1l1 \-PA IOrm 
hcinc urine I’,4 I ooa 
Crude porcine urine I r1cra 
--- .-_---__.--__-__II-L 
affected by amiloride, an inhibitor of u-PA from various 
species, including porcine u-PA [20] (Table II). 
Identification of porcine urine PA as a tissue-type PA 
is further supported by marked activity enhancement in 
the presence of fibrin. When lysis areas in the fibrin 
plate assay are plotted vs log of enzyme concentration, 
parallel lines are obtained for porcine urine PA and 
human t-PA, while the linear dependency for human 
u-PA is much steeper. In the coupled amidolytic assay 
CNBr-fragments of fibrinogen stimulate plasminogen 
activation by porcine urine PA and by human t-PA 
about 65-fold (Fig. 4). Plasminogen activation by 
human u-PA is accelerated only 2-fold (data not 
shown). 
4. DISCUSSION 
PA are present in most, if not all mammalian body 
fluids. They are synthesized by a variety of mammalian 
cells. PA synthesis is regulated by many factors and the 
quantity and prevailing type of PA in different tissues 
and in the same tissue of different species varies [21]. 
There is, however, up to now, only one example where 
the same cell type of two closely related species secretes 
distinct, but functionally similar types of PA into a body 
fluid; mouse ovarian granulosa cells produce u-PA, 
whereas rat ovarian granulosa cells secrete t-PA into the 
follicular fluid [22]. 
It is well established that human urine contains u-PA 
and u-PA purified from human urine has been widely 
used for thrombolytic therapy [23]. Since u-PA was also 
found in other urines investigated, as mouse, rat [5] and 
bovine urine [6], the generally held view is, that urine of 
mammalian species contains u-PA. It therefore comes 
as a surprise that porcine urine does not contain u-PA. 
The present comparative study of porcine urine PA, 
human t-PA. and human u-PA reveals that norcine 
urine 
:-PA. 
PA is of the tissue-type. It behaves likeLhuman 
and unlike human u-PA with respect to M,, im- 
I---- -. ___~_ I 
[p-Anti -PA IgGl. lg/ml 
Fig. 3. 1Xfcc1 of antibodies on PA activity. in a fibrin plate assay. 
hliquols containing 0.05 pug human t-PA/ml (, ,,*, or 0.07 ,ug porch2 
urine I’NrnI (,‘,,A) wcrc incubated for I Ii ilt 37°C with diffcrcnt 
conwnIrutioii6 of polyolon;~l ultti-t-PA :rntibody ( ,;‘.) or polyclond 
anti-u-PA antibody (o.A). rcspcctivcly. 5jrl samples \vcrs then applied 
IO IIOICS ~UIICIUXI into the fibrh pla~c. Lysis iIrc;Is wrc mc;trurcd after 
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Fig. 4. Stimulation of plasminogen activation rate by fibrin. Plasmino- 
gcn activating activity of 0.125 ,@ml human t-PA (c.e) and 0.15 
PgIrnl porcine urine PA (v.A) were estimated spectrophotometrically 
with the plasmin substrate D-Val-Leu-Lys-p-nitroanilide in the pres- 
ence (0.n) or absence (@.A) of CNBr-fragments of fibrinogen, respec- 
tively. 
munoreactivity, inhibition of activity by antibodies and 
amiloride, and stimulation of activity by fibrinogen 
fragments. In addition, properties of purcine urine PA 
compare well with the properties of purified porcine 
heart t-PA. 
The amount of t-PA in porcine urine is rather low. 
Quantities of 0.5-5.0 ng/ml have been measured with an 
EIA for human t-PA. These low values correspond to 
low PA activity documented in fibrin plate and zymo- 
graphic assays of porcine urine. The u-PA-content in 
human urine is much higher and amounts to 40-100 
@ml [23]. 
An explanation for the observed differences in PA 
content of porcine urine as compared to urine of other 
mammalian species cannot be given yet. It is anticipated 
however that a comparative analysis of PA synthesis 
and degradation in the urinary tract of pig and other 
mammalia will provide a clue. Recently Sappino et al. 
[9] found equivalent catalytic amounts of t-PA and u- 
PA in pelvic urine of the mouse, while in excreted mu- 
rine urine mainly u-PA and only traces of t-PA were 
detected. The loss of t-PA along the urinary tract was 
not investigated. 
Identification of porcine urine PA as a t-PA rests for 
a large part on cross-reactivity of antibodies against 
human t-PA with porcine t-PA. This cross-reactivity has 
been noted before: polyclonal anti-porcine t-PA antibod- 
ies quench the activity of human plasma and uterine 
t-PA [24]. Three out of six monoclonal anti-human t-PA 
antibodies obtained by Stigbrand et al. [25] cross-react 
with porcine heart t-PA. Our pane1 of 21 mAb against 
human t-PA exhibits an even higher percentage of cross- 
reactivity. Together, these results evidence an extended 
similarity in structure of porcine and human t-PA. 
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